Qbiotics, page-149

Standard of care treatment which Stelfonta will be substituting for is surgery/ excision, and chemo which is not that effective. And Gordon has implied cost will be matched. Imagine that these will cost more than $500.
Next markets which qbiotics are pursuing will be China and Japan. Needs registration in these countries which will be very dignificant. So revenue building with Stelfonta still very much in its infancy.

Again ridiculous that vets don't have access in Oz. Laughable